Theriva Biologics, Inc.: Theriva Biologics Announces Orphan

Theriva Biologics, Inc.: Theriva Biologics Announces Orphan Drug Designation Granted by the U.S. FDA for VCN-01 for the Treatment of Pancreatic Cancer

Theriva Biologics, Inc.: Theriva Biologics Announces Orphan Drug Designation Granted by the U.S. FDA for VCN-01 for the Treatment of Pancreatic Cancer

finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Related Keywords

United States , Spain , American , Spanish , Theriva Biologics , Stevena Shallcross , Chris Calabrese , Drug Administration , Theriva Biologics Inc , Lifesci Advisors , Company Annual Report On Form , Office Of Orphan Products Development , Chief Executive Officer , Orphan Products Development , Orphan Drug Designation , Spanish Clinical Trials Registry , Private Securities Litigation Reform Act , Europe These , Annual Report , Sci Advisors ,